Table 1 Characteristics of patients
Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
FDG PET/CT scans (n) | 20 | 28 | 15 |
Patients (n) | 6 | 18 | 5 |
Men/women | 3/3 | 9/9 | 2/3 |
Age (years) | 67 ± 10 | 74 ± 9 | 65 ± 13 |
Weight (kilograms) | 72 ± 10 | 67 ± 10 | 67 ± 10 |
Body Mass Index (kilogram/square meter) | 25.7 ± 5.2 | 25.0 ± 3.8 | 24.2 ± 4.1 |
Histology | |||
Papillary | 3 | 13 | 2 |
Follicular | 2 | 4 | 1 |
Poorly differentiated | 1 | 1 | 2 |
PET on TKI (n) | |||
Sorafenib | 20 | 0 | 0 |
Sunitinib | 0 | 0 | 4 |
Vandetanib | 0 | 0 | 11 |
Patient status (n) | |||
On suppressive LT4 therapy | 20 | 23 | 15 |
Off LT4 | 0 | 2 | 0 |
After recombinant human thyrotropin | 0 | 3 | 0 |